Mesenchymal Stem/Stromal Cells as a Therapeutic Tool in Cell-Based Therapy and Regenerative Medicine: An Introduction Expertise to the Topical Collection.

Authors : Merimi M, Fahmi H, De Kock J, Beguin C, Burny A, Moll G, Poggi A, Najar M
Year : 2022
Journal : Cells
Volume : 11

Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.

Authors : Latacz E, Höppener D, Bohlok A, Leduc S, Tabariès S, Fernández Moro C, Lugassy C, Nyström H, Bozóky B, Floris G, Geyer N, Brodt P, Llado L, Van Mileghem L, De Schepper M, Majeed AW, Lazaris A, Dirix P, Zhang Q, Petrillo SK, Vankerckhove S, Joye I, Meyer Y, Gregorieff A, Roig NR, Vidal-Vanaclocha F, Denis L, Oliveira RC, Metrakos P, Grünhagen DJ, Nagtegaal ID, Mollevi DG, Jarnagin WR, DAngelica MI, Reynolds AR, Doukas M, Desmedt C, Dirix L, Donckier V, Siegel PM, Barnhill R, Gerling M, Verhoef C, Vermeulen PB
Year : 2022
Journal : Br J Cancer
Volume : 127
Pages : 988-1013

Ovarian Clear Cell Carcinoma with Functioning Stroma and Associated Endometrial Intraepithelial Neoplasia.

Authors : Desimpel F, Noël JC, Verset L, Sirtaine N, Buxant F
Year : 2022
Journal : Case Rep Obstet Gynecol
Volume : 2022
Pages : 5538390

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

Authors : Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA
Year : 2022
Journal : N Engl J Med
Volume : 387
Pages : 9-20

Radiomics software comparison using digital phantom and patient data: IBSI-compliance does not guarantee concordance of feature values.

Authors : Paquier Z, Chao SL, Acquisto A, Fenton C, Guiot T, Dhont J, Levillain H, Gulyban A, Bali MA, Reynaert N
Year : 2022
Journal : Biomed Phys Eng Express
Volume : 8

Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis.

Authors : Chouha N, Abou-Hamdan H, Yurugi H, Yoshii R, Ii H, Najem A, Ghanem GE, Nakata S, Rajalingam K, Peng Y, Wang D, Nebigil CG, Désaubry L
Year : 2022
Journal : Eur J Med Chem
Volume : 242
Pages : 114635

OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.

Authors : Otmani K, Rouas R, Lewalle P
Year : 2022
Journal : Front Immunol
Volume : 13
Pages : 913951

Urinary microbiota and prostatic diseases: the key for the lock? A systematic review.

Authors : Mjaess G, Karam A, Roumeguère T, Diamand R, Aoun F, McVary K, Moul JW, DE Nunzio C, Albisinni S
Year : 2022
Journal : Prostate Cancer Prostatic Dis

Salvage Partial Laryngectomy after Failed Radiotherapy: Oncological and Functional Outcomes.

Authors : Gigot M, Digonnet A, Rodriguez A, Lechien JR
Year : 2022
Journal : J Clin Med
Volume : 11

Efficacy and Safety of Tranexamic Acid in Cancer Surgery. An Update of Clinical Findings and Ongoing Research.

Authors : Zec T, Di Napoli R, Fievez L, Ben Aziz M, Ottaiano A, Vittori A, Perri F, Cascella M
Year : 2022
Journal : J Multidiscip Healthc
Volume : 15
Pages : 1427-1444

Extracellular vesicle secretion by leukemia cells in vivo promotes CLL progression by hampering antitumor T-cell responses.

Authors : Gargiulo E, Viry E, Morande PE, Largeot A, Gonder S, Xian F, Ioannou N, Benzarti M, Kleine Borgmann FB, Mittelbronn M, Dittmar G, Nazarov PV, Meiser J, Stamatopoulos B, Ramsay AG, Moussay E, Paggetti J
Year : 2022
Journal : Blood Cancer Discov

[Prostate cancer, androgen deprivation, and risk of COVID-19 infection : A systematic review and meta-analysis].

Authors : Manolache NG, Mjaess G, Diamand R, Albisinni S, Roumeguère T
Year : 2022
Journal : Prog Urol
Volume : 32
Pages : 1421-1430

Intra-Cavernosal Injection of Botulinum Toxin in the Treatment of Erectile Dysfunction: a Systematic Review and Meta-Analysis.

Authors : Abou Zahr R, Bou Kheir G, Mjaess G, Jabbour T, Chalhoub K, Diamand R, Roumeguère T
Year : 2022
Journal : Urology
Volume : 170
Pages : 5-13

Fundamental and Applied Advances in Stem Cell Therapeutic Research.

Authors : Merimi M, Rahmani S, Afailal Tribak A, Bouhtit F, Fahmi H, Najar M
Year : 2022
Journal : Cells
Volume : 11

CAR-T Cell Therapy for Solid Tumors: Are we Still That Far? a Systematic Review of Literature.

Authors : Karam A, Mjaess G, Martinez Chanza N, Aoun F, Bou Kheir G, Younes H, Kazzi H, Albisinni S, Roumeguère T
Year : 2022
Journal : Cancer Invest
Pages : 1-15

Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study.

Authors : Le Calvez B, Tessoullin B, Renaud L, Botella-Garcia C, Srour M, Le Gouill S, Guillerm G, Gressin R, Nguyen Quoc S, Furst S, Chauchet A, Sibon D, Lewalle P, Poiré X, Maillard N, Villate A, Loschi M, Paillassa J, Beguin Y, Dulery R, Tudesq JJ, Fayard A, Béné MC, Camus V, Chevallier P, Le Bourgeois A
Year : 2022
Journal : Acta Oncol
Volume : 61
Pages : 1332-1338

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials.

Authors : Chumsri S, Li Z, Serie DJ, Norton N, Mashadi-Hossein A, Tenner K, Brauer HA, Warren S, Danaher P, Colon-Otero G, Partridge AH, Carey LA, Hilbers F, van Dooren V, Holmes E, Di Cosimo S, Werner O, Huober JB, Dueck AC, Sotiriou C, Saura C, Moreno-Aspitia A, Knutson KL, Perez EA, Thompson EA
Year : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pages : 68

Heterotopic ossification and severe COVID-19 infection.

Authors : Benkhaled S, Gomes da Silveira Cauduro C, Alexiou J, Jayankura M, Van Gestel D
Year : 2022
Journal : QJM
Volume : 115
Pages : 201-203

Antimicrobial susceptibility testing determined by Alfred 60/AST (Alifax®) in a multi-sites lab: performance's evaluation and optimization of workflow.

Authors : Cupaiolo R, Cherkaoui S, Serrano G, Dauby N, Georgala A, Blumental S, Maillart E, Hites M, Hallin M, Martiny D
Year : 2022
Journal : J Microbiol Methods
Volume : 194
Pages : 106433

Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial.

Authors : Schwarze JK, Garaud S, Jansen YJL, Awada G, Vandersleyen V, Tijtgat J, de Wind A, Kristanto P, Seremet T, Willard-Gallo K, Neyns B
Year : 2022
Journal : Cancers (Basel)
Volume : 14